Researchers consider why Wegovy provides heart benefits beyond weight loss

The car­dio­vas­cu­lar ben­e­fits of No­vo Nordisk’s block­buster weight loss drug We­govy are not de­pen­dent on the amount of weight pa­tients lost, ac­cord­ing to a new analy­sis.

The find­ings from the analy­sis of No­vo’s SE­LECT tri­al sug­gest that the heart pro­tec­tion of­fered by We­govy goes be­yond the car­dio­vas­cu­lar im­prove­ments that come from weight loss. How­ev­er, re­searchers said that they can’t yet pin­point what is dri­ving the treat­ment’s ben­e­fi­cial ef­fects on heart health.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.